drugset / Trial / NCT03024476
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance
Phase 2
Completed
67 enrolled
Seoul National University Bundang Hospital
Daiichi Sankyo Korea Co., Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
BOSS-Trial I is a phase 2 clinical trial with the following objectives; 1. to prove the feasibility of a Bluetooth-equipped sphygmomanometer system in real-world clinical practice and wireless connection to the main server; 2. to prove the feasibility of the BP management strategy, including the pre-specified BP range, BP management algorithm, and behavioral; and 3. to gather information for the phase 3 trial including BP variability indices and their potentials as a treatment guidance.
Timeline
- Start
- 2016-09-01
- Primary completion
- 2017-12-07
- Completion
- 2017-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Olmesartan | Other / unclassified | 20 mg | — |
| Subject | Olmesartan | Other / unclassified | 40 mg | — |